Clinical Trial Update: Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 study evaluating potential pharmacokinetic interactions when metformin is taken with GSK189075 in adults with Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GSK189075 (GSK189075)
• metformin (metformin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Type 2 Diabetes Mellitus, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED